USA. DEA Finalizes Measures to Expand Medication-Assisted Treatment - Improved access will benefit rural and underserved areas with limited treatment options

WASHINGTON – The Drug Enforcement Administration today announced an important step to improve access to medications for opioid use disorder, especially in rural areas where those suffering with opioid use disorder may have limited treatment options.

Under the final rule published today, DEA registrants who are authorized to dispense methadone for opioid use disorder would be authorized to add a “mobile component” to their existing registration – eliminating the separate registration requirement for these mobile narcotic treatment programs (NTPs). This will streamline the registration process and make it easier for registrants to provide needed services in remote or underserved areas. The rule also outlines the reports and records that shall be maintained for NTPs that wish to expand the reach of their treatment programs by use of mobile components. (DEA – Drug Enforcement Administration, USA, 28.06.2021)

https://www.dea.gov/press-releases/2021/06/28/dea-finalizes-measures-expand-medication-assisted-treatment